Latest Capital Raises News

Norwood Systems has extended its cash drawdown facility for the sixth time, increasing the principal to $732,189.69 and pushing the repayment deadline to late February 2025.

Macarthur Minerals Limited reported a comprehensive loss of AUD 252,771 for Q4 2024, marking a sharp reversal from the prior year's profit. The company is navigating reduced exploration spending and strategic asset sales while facing ongoing funding challenges.

Macarthur Minerals Limited reported a substantial loss of A$25.6 million for the nine months ending December 31, 2024, driven largely by the sale of its Hematite Project. Despite this setback, the company outlines plans for future funding and operational adjustments to sustain its business.

Eagle Mountain Mining has issued over 202 million new shares and 50 million options, raising $1.62 million through its recent entitlement offer. The company is poised to complete the underwritten shortfall, potentially increasing its capital base further.

Scorpion Minerals Limited has had its trading suspension lifted following an announcement about a potential joint venture and capital raising, signaling renewed market activity.

Scorpion Minerals has expanded its footprint in the Murchison Gold Province through a strategic farm-in and joint venture agreement with E79 Gold Mines, aiming to earn a 70% stake in the Jungar Flats Gold Project. Supported by a $1.5 million placement, the company is poised to commence drilling on high-grade targets imminently.

Forbidden Foods Limited has raised $1 million to boost inventory for its Blue Dinosaur and Oat Milk Goodness brands, following a remarkable 104% jump in quarterly sales.

Asara Resources has raised $2.3 million through a placement led by Barbet L.L.C FZ to advance exploration at its Kada Gold Project in Guinea, coinciding with the appointment of Matthew Sharples as CEO.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.